AstraZeneca states it will likely do another study of COVID-19 vaccine after unexpected lower dosage reveals greater effectiveness thumbnail

AstraZeneca’s CEO informed Bloomberg that the pharmaceutical company will likely carry out another global trial of the efficiency of its COVID-19 vaccine trial, following the disclosure that the more reliable dosage in the existing Phase 3 scientific trial was really administered by mishap. AstraZeneca and its partner the University of Oxford reported interim results that showed […]
Find Out More

By Admin